famotidine and cisapride

famotidine has been researched along with cisapride in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horikoshi, T; Kobayashi, S; Kusano, M; Matsuzaki, T; Nishioka, T; Ohwada, T; Sekiguchi, T; Sugiyama, M; Toki, M1
Dallera, F; Gendarini, A; Scanzi, G1
Berstad, A; Hatlebakk, JG1
Itoh, Z; Matsunaga, Y; Tamaki, H; Ueki, S; Yoneta, T1
Grodzieński, R; Radwan, P; Skrzydło-Radomańska, B; Słomka, M; Wysokiński, A; Zaorska-Rajca, J1
Adachi, K; Fujishiro, H; Kawamura, A; Kinoshita, Y; Ono, M; Yuki, M1
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1

Reviews

1 review(s) available for famotidine and cisapride

ArticleYear
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Clinical pharmacokinetics, 1996, Volume: 31, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides

1996

Trials

1 trial(s) available for famotidine and cisapride

ArticleYear
[The effect of prokinetic treatment and eradication of Helicobacter pylori on gastric emptying and symptoms of functional dyspepsia].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2001, Volume: 54, Issue:1-2

    Topics: Adolescent; Adult; Cisapride; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Male

2001

Other Studies

10 other study(ies) available for famotidine and cisapride

ArticleYear
Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
    Gastroenterologia Japonica, 1991, Volume: 26, Issue:2

    Topics: Adult; Aged; Chronic Disease; Cisapride; Esophagitis, Peptic; Esophagus; Famotidine; Female; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Piperidines; Serotonin Antagonists; Stomach

1991
[Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
    La Clinica terapeutica, 1994, Volume: 144, Issue:1

    Topics: Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Famotidine; Female; Gastritis; Gastrointestinal Motility; Humans; Male; Piperidines; Pyloric Antrum

1994
Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
    Arzneimittel-Forschung, 1999, Volume: 49, Issue:7

    Topics: Animals; Anti-Ulcer Agents; Cimetidine; Cisapride; Digestion; Dogs; Duodenum; Famotidine; Gastric Emptying; Gastrointestinal Motility; Injections, Intravenous; Intubation, Gastrointestinal; Male; Nizatidine; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Stomach

1999
Nizatidine and cisapride enhance salivary secretion in humans.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:2

    Topics: Adult; Anti-Ulcer Agents; Bicarbonates; Case-Control Studies; Cisapride; Epidermal Growth Factor; Famotidine; Humans; Male; Nizatidine; Saliva; Salivation

2002
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010